- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03759145
The Jintronix Interactive System for Upper Extremity Rehabilitation Training Post Stroke
November 28, 2018 updated by: Dahlia Kairy, Université de Montréal
The Jintronix Interactive System for Upper Extremity Rehabilitation Training Post Stroke: A Pilot Study
Stroke is a leading cause of death and disability worldwide.Hemiplegia, weakness of one side of the body, is a common consequence of stroke that can lead to significant functional impairments.
Loss of arm function occurs in up to 85% of stroke survivors.
The impact of arm-related limitations on activities of daily living, leisure activities or work is significant as the arm plays a central role in a person's life from the ability to perform basic activities of daily life to carrying out family and social roles.
Guidelines indicate that rehabilitation can improve upper extremity (UE) motor control and functional status post stroke.
Virtual reality (VR) and computer games are recent technologies that, as they become more accessible and affordable,are increasingly being used in rehabilitation to allow patients to engage in repetitive practice of specific tasks.
A number of published reviews and meta-analyses have examined the use of VR and video games for post-stroke rehabilitation, focusing on or including UE rehabilitation.
The authors agree that there is limited but promising findings that VR and video-games, when combined with traditional rehabilitation, have a positive impact on recovery post-stroke.
Study Overview
Detailed Description
The goal of the study is to assess the feasibility, safety, and acceptability of the Jintronix system, as well as provide preliminary evidence regarding the clinical efficacy for post-stroke rehabilitation.This is a pilot parallel randomised single-blinded controlled trial, with patients who have had a stroke randomly allocated to one of two groups: (1) usual rehabilitation services and additional training with Jintronix system (treatment group) or (2) usual rehabilitation services only (control group).
Study Type
Interventional
Enrollment (Actual)
18
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Quebec
-
Montréal, Quebec, Canada, H3N 1X7
- Université de Montréal
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
14 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- having had an ischemic or hemorrhagic stroke for the first time;
- having residual mild to moderate UE impairment (score 3-6 on the Chedoke-McMaster arm component, as long as exergames can be played);
- being in subacute stage (within 6 months post-stroke);
- receiving usual out-patient rehabilitation services at one of the two selected rehabilitation sites, located in the greater Montreal area in Canada.
Exclusion Criteria:
- being medically unstable;
- having severe cognitive or communication deficits;
- having visual impairments limiting use of the exergame;
- having any medical contraindication for shoulder movements;
- having severe balance deficits limiting sitting safely independently;
- having previous upper limb impairment limiting potential recovery;
- having any other impairment that limited use of the exergame.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention arm, usual rehabilitation + Jintronix exergame
On top of the usual out-patient rehabilitation sessions planned for the participant, participants attend sessions to use the Jintronix system for up 30 minutes up to 3 times per week
|
Participants use exergame with the therapist in the rehabilitation center.
Several games are available, the therapist adjusts the choice of game and level of difficulty according to the participant's abilities and interests.
|
|
Other: Control group
Participants continue their prescribed rehabilitation sessions
|
participants continued their planned rehabilitation sessions
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
number of sessions (feasibility)
Time Frame: 4 week period
|
number of sessions the participant used the system during the study period
|
4 week period
|
|
duration of sessions
Time Frame: 4 week period (ongoing)
|
the average duration of sessions (minutes)
|
4 week period (ongoing)
|
|
time spent by therapist assisting the participant
Time Frame: 4 week period (ongoing)
|
time during the sessions that the therapist spent assisting the participant (minutes)
|
4 week period (ongoing)
|
|
time spent on each exergame
Time Frame: 4 week period (ongoing)
|
the time spent on each exergame (minutes)
|
4 week period (ongoing)
|
|
adverse event (counts)
Time Frame: 4 week period (ongoing)
|
occurrence of adverse events such as falls, motion sickness, dizziness and headaches
|
4 week period (ongoing)
|
|
adverse event (borg exertion scale, self-reported scale 6-20, (Borg Exertion Scale scored from 6-20, no exertion to maximal exertion)
Time Frame: 4 week period (ongoing)
|
exertion after playing the exergame reported using the Borg Exertion Scale
|
4 week period (ongoing)
|
|
adverse event (pain self reported on visual analog scale 0-10)
Time Frame: 4 week period (ongoing)
|
pain after playing the exergame reported using visual analog scale 0-10, 0 is no pain, 10 is the worse pain imaginable.
|
4 week period (ongoing)
|
|
Stroke-specific measure of quality of life - Stroke Impact Scale
Time Frame: 4 week period (per-post)
|
Stroke Impact Scale is a questionnaire of the impact that the stroke is having on function, mood, emotional status, total score 0-100, with with higher scores indicating better self-reported health.
|
4 week period (per-post)
|
|
upper limb function assessed using the Motor Activity Log
Time Frame: 4 week period (per-post)
|
The Motor Activity Log is a questionnaire that the participant completes reporting how much the impaired upper limb is used for various daily tasks, each task is scored from 0-5 (ordinal scale, 0=do not use arm - 6=use as much as before), total score is mean of the scores.
|
4 week period (per-post)
|
|
upper limb function assessed using the Box and Block test
Time Frame: 4 week period (per-post)
|
upper limb function is assessed using the box and block test where participants are timed while picking up and placing wooden cubes
|
4 week period (per-post)
|
|
upper limb motor control assessed using the Fugl-Meyer Assessment-upper extremity
Time Frame: 4 week period (per-post)
|
Upper limb motor control is assessed using a valid and reliable outcome, measure consisting of tasks to be performed by the participant, scores between 0-66, higher scores indicating better motor control.
|
4 week period (per-post)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 1, 2014
Primary Completion (Actual)
January 1, 2016
Study Completion (Actual)
January 1, 2016
Study Registration Dates
First Submitted
November 27, 2018
First Submitted That Met QC Criteria
November 27, 2018
First Posted (Actual)
November 29, 2018
Study Record Updates
Last Update Posted (Actual)
November 30, 2018
Last Update Submitted That Met QC Criteria
November 28, 2018
Last Verified
November 1, 2018
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- CRIR-795-0113
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
National Assembly ClinicBayero University Kano, NigeriaRecruitingStroke | Stroke Hemorrhagic | Stroke Ischemic | Hemiparesis After StrokeNigeria
-
University of PittsburghRecruitingHemorrhagic Stroke | Embolic Stroke of Undetermined Source | Ischemic Stroke, Cryptogenic | Recurrent Ischemic Stroke | Ischemic Stroke, EmbolicUnited States
-
Mahidol UniversityNot yet recruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke SurvivorsThailand
-
Mahidol UniversityRecruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke PatientThailand
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
Fondazione Don Carlo Gnocchi OnlusScuola Superiore Sant'Anna di Pisa; Fondazione Policlinico Universitario Campus...Not yet recruitingStroke | Stroke Hemorrhagic | Upper Limb Rehabilitation | Stroke IschemicItaly
-
Samsung Medical CenterCompletedChronic Stroke | Subacute Stroke | ExoskeletonSouth Korea
-
University of Illinois at ChicagoRecruitingStroke, Ischemic | Stroke Hemorrhagic | Stroke, CerebrovascularUnited States
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
Clinical Trials on Exergame
-
MaineHealthRobert Wood Johnson FoundationCompleted
-
University of California, Los AngelesNational Institute on Aging (NIA); BioSensicsActive, not recruitingCognitive Impairment | Dementia | Mild Cognitive Impairment | Memory LossUnited States
-
Chang Gung UniversityCompleted
-
University of MinnesotaCompletedPreclinical Alzheimer's DiseaseUnited States
-
University of ZurichCompletedVestibular DiseasesSwitzerland
-
University of JaénNot yet recruitingExercise | Pregnant Women | Game
-
Eling DeBruinCompletedMild Neurocognitive DisorderSwitzerland
-
National Yang Ming UniversityUnknown
-
Eling DeBruinRecruitingMultiple SclerosisSwitzerland
-
Swiss Federal Institute of TechnologyCompletedEffects of Exergaming on Cognitive Functions in Young AthletenSwitzerland